Side effects include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth, blurred vision or change in near or distant vision, and eye pain.
A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Dipyridamole | The therapeutic efficacy of Physostigmine can be decreased when used in combination with Dipyridamole. |
| Ephedrine | Physostigmine may increase the neuromuscular blocking activities of Ephedrine. |
| Bambuterol | Physostigmine may increase the neuromuscular blocking activities of Bambuterol. |
| Clevidipine | Physostigmine may increase the neuromuscular blocking activities of Clevidipine. |
| Sar9, Met (O2)11-Substance P | Physostigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Mirabegron | Physostigmine may increase the neuromuscular blocking activities of Mirabegron. |
| Moxisylyte | Physostigmine may increase the neuromuscular blocking activities of Moxisylyte. |
| Propacetamol | Physostigmine may increase the neuromuscular blocking activities of Propacetamol. |
| Procaine | Physostigmine may increase the neuromuscular blocking activities of Procaine. |
| Cocaine | Physostigmine may increase the neuromuscular blocking activities of Cocaine. |
| Trimethaphan | Physostigmine may increase the neuromuscular blocking activities of Trimethaphan. |
| Doxacurium | Physostigmine may increase the neuromuscular blocking activities of Doxacurium. |
| Chloroprocaine | Physostigmine may increase the neuromuscular blocking activities of Chloroprocaine. |
| Tubocurarine | Physostigmine may increase the neuromuscular blocking activities of Tubocurarine. |
| Aclidinium | Physostigmine may increase the neuromuscular blocking activities of Aclidinium. |
| Butyrylthiocholine | Physostigmine may increase the neuromuscular blocking activities of Butyrylthiocholine. |
| Oxybuprocaine | Physostigmine may increase the neuromuscular blocking activities of Oxybuprocaine. |
| Benzonatate | Physostigmine may increase the neuromuscular blocking activities of Benzonatate. |
| Succinylcholine | The metabolism of Succinylcholine can be decreased when combined with Physostigmine. |
| Tramadol | The therapeutic efficacy of Tramadol can be decreased when used in combination with Physostigmine. |
| Trospium | The therapeutic efficacy of Trospium can be decreased when used in combination with Physostigmine. |
| Oxyphenonium | The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Physostigmine. |
| Butabarbital | The therapeutic efficacy of Butabarbital can be decreased when used in combination with Physostigmine. |
| Butalbital | The therapeutic efficacy of Butalbital can be decreased when used in combination with Physostigmine. |
| Benzatropine | The therapeutic efficacy of Benzatropine can be decreased when used in combination with Physostigmine. |
| Ziprasidone | The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Physostigmine. |
| Disopyramide | The therapeutic efficacy of Disopyramide can be decreased when used in combination with Physostigmine. |
| Talbutal | The therapeutic efficacy of Talbutal can be decreased when used in combination with Physostigmine. |
| Pentobarbital | The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Physostigmine. |
| Amitriptyline | The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Physostigmine. |
| Ipratropium | The therapeutic efficacy of Ipratropium can be decreased when used in combination with Physostigmine. |
| Methadone | The therapeutic efficacy of Methadone can be decreased when used in combination with Physostigmine. |
| Olanzapine | The therapeutic efficacy of Olanzapine can be decreased when used in combination with Physostigmine. |
| Metixene | The therapeutic efficacy of Metixene can be decreased when used in combination with Physostigmine. |
| Terfenadine | The therapeutic efficacy of Terfenadine can be decreased when used in combination with Physostigmine. |
| Buclizine | The therapeutic efficacy of Buclizine can be decreased when used in combination with Physostigmine. |
| Clozapine | The therapeutic efficacy of Clozapine can be decreased when used in combination with Physostigmine. |
| Doxylamine | The therapeutic efficacy of Doxylamine can be decreased when used in combination with Physostigmine. |
| Trihexyphenidyl | The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Physostigmine. |
| Oxyphencyclimine | The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Physostigmine. |
| Procyclidine | The therapeutic efficacy of Procyclidine can be decreased when used in combination with Physostigmine. |
| Profenamine | The therapeutic efficacy of Profenamine can be decreased when used in combination with Physostigmine. |
| Secobarbital | The therapeutic efficacy of Secobarbital can be decreased when used in combination with Physostigmine. |
| Promazine | The therapeutic efficacy of Promazine can be decreased when used in combination with Physostigmine. |
| Hyoscyamine | The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Physostigmine. |
| Cyproheptadine | The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Physostigmine. |
| Imipramine | The therapeutic efficacy of Imipramine can be decreased when used in combination with Physostigmine. |
| Methscopolamine bromide | The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Physostigmine. |
| Metharbital | The therapeutic efficacy of Metharbital can be decreased when used in combination with Physostigmine. |
| Fluoxetine | The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Physostigmine. |
| Chlorpromazine | The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Physostigmine. |
| Darifenacin | The therapeutic efficacy of Darifenacin can be decreased when used in combination with Physostigmine. |
| Tridihexethyl | The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Physostigmine. |
| Triflupromazine | The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Physostigmine. |
| Dextromethorphan | The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Physostigmine. |
| Anisotropine methylbromide | The therapeutic efficacy of Anisotropine methylbromide can be decreased when used in combination with Physostigmine. |
| Nortriptyline | The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Physostigmine. |
| Amoxapine | The therapeutic efficacy of Amoxapine can be decreased when used in combination with Physostigmine. |
| Atropine | The therapeutic efficacy of Atropine can be decreased when used in combination with Physostigmine. |
| Thiopental | The therapeutic efficacy of Thiopental can be decreased when used in combination with Physostigmine. |
| Nicardipine | The therapeutic efficacy of Nicardipine can be decreased when used in combination with Physostigmine. |
| Mecamylamine | The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Physostigmine. |
| Pirenzepine | The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Physostigmine. |
| Paroxetine | The therapeutic efficacy of Paroxetine can be decreased when used in combination with Physostigmine. |
| Homatropine methylbromide | The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Physostigmine. |
| Scopolamine | The therapeutic efficacy of Scopolamine can be decreased when used in combination with Physostigmine. |
| Isoflurane | The therapeutic efficacy of Isoflurane can be decreased when used in combination with Physostigmine. |
| Benzquinamide | The therapeutic efficacy of Benzquinamide can be decreased when used in combination with Physostigmine. |
| Clidinium | The therapeutic efficacy of Clidinium can be decreased when used in combination with Physostigmine. |
| Propiomazine | The therapeutic efficacy of Propiomazine can be decreased when used in combination with Physostigmine. |
| Propantheline | The therapeutic efficacy of Propantheline can be decreased when used in combination with Physostigmine. |
| Primidone | The therapeutic efficacy of Primidone can be decreased when used in combination with Physostigmine. |
| Dicyclomine | The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Physostigmine. |
| Biperiden | The therapeutic efficacy of Biperiden can be decreased when used in combination with Physostigmine. |
| Brompheniramine | The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Physostigmine. |
| Methylphenobarbital | The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Physostigmine. |
| Quinidine | The therapeutic efficacy of Quinidine can be decreased when used in combination with Physostigmine. |
| Amantadine | The therapeutic efficacy of Amantadine can be decreased when used in combination with Physostigmine. |
| Maprotiline | The therapeutic efficacy of Maprotiline can be decreased when used in combination with Physostigmine. |
| Methantheline | The therapeutic efficacy of Methantheline can be decreased when used in combination with Physostigmine. |
| Hexafluronium | The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Physostigmine. |
| Cycrimine | The therapeutic efficacy of Cycrimine can be decreased when used in combination with Physostigmine. |
| Desloratadine | The therapeutic efficacy of Desloratadine can be decreased when used in combination with Physostigmine. |
| Glycopyrronium | The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Physostigmine. |
| Tolterodine | The therapeutic efficacy of Tolterodine can be decreased when used in combination with Physostigmine. |
| Oxybutynin | The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Physostigmine. |
| Promethazine | The therapeutic efficacy of Promethazine can be decreased when used in combination with Physostigmine. |
| Diphenhydramine | The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Physostigmine. |
| Pentolinium | The therapeutic efficacy of Pentolinium can be decreased when used in combination with Physostigmine. |
| Doxepin | The therapeutic efficacy of Doxepin can be decreased when used in combination with Physostigmine. |
| Flavoxate | The therapeutic efficacy of Flavoxate can be decreased when used in combination with Physostigmine. |
| Desipramine | The therapeutic efficacy of Desipramine can be decreased when used in combination with Physostigmine. |
| Orphenadrine | The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Physostigmine. |
| Phenobarbital | The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Physostigmine. |
| Escitalopram | The therapeutic efficacy of Escitalopram can be decreased when used in combination with Physostigmine. |
| Quetiapine | The therapeutic efficacy of Quetiapine can be decreased when used in combination with Physostigmine. |
| Levacetylmethadol | The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Physostigmine. |
| Diphenidol | The therapeutic efficacy of Diphenidol can be decreased when used in combination with Physostigmine. |
| Aripiprazole | The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Physostigmine. |
| Chlorprothixene | The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Physostigmine. |